EUVIMEDEUVIMED entdecken
Open Access

Phenylacetic Acid, a Gut Microbially Produced Metabolite, Reduces Atherosclerosis Burden and Impacts Host Lipid Homeostasis

Kelley M Carr iD, Jiyeon Kim iD, Junchul Shin iD, Kathryn A Bacik iD, Junyoung Hong iD, Irene Krukovets, Christopher M Strauch iD, Naseer Sangwan iD, Olga A Cherepanova iD, Ina Nemet iD

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.047044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Kelley M Carr und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular and Metabolic Sciences Cleveland Clinic Research Cleveland OH USA. Hauptthemen laut MEDLINE: Phenylacetates, Atherosclerosis, Gastrointestinal Microbiome, Lipid Metabolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gut microbial metabolism of dietary phenylalanine produces phenylacetic acid (PAA), followed by the host conversion to phenylacetylglutamine in humans and phenylacetylglycine in mice. Phenylacetylglutamine was linked to cardiovascular disease risk in multiple clinical studies, yet whether the microbial pathways leading to PAA/phenylacetylglutamine/phenylacetylglycine formation influence atherosclerosis progression within the host remains elusive.

Methods

Atheroprone Apoe −/− mice on a Western diet were provided with a gut microbial metabolite PAA to investigate its effects on host cardiometabolic health.

Results

Circulating levels of phenylacetylglutamine and phenylacetylglycine were increased by the treatment without affecting circulating cholesterol or inflammatory cytokines. In male mice, PAA elevated triglycerides and fasting glucose. PAA decreased the total atherosclerotic plaque burden within the descending and abdominal aortas of both sexes and within brachiocephalic arteries in male mice without affecting plaque stability indices. PAA altered gut microbial composition but did not markedly shift production of established atherosclerosis‐related microbial metabolites, aside from a modest rise in indoxyl sulfate in female mice. Furthermore, PAA treatment decreased circulating levels of acyl‐ and free carnitines through reduced availability of their biosynthetic precursors and upregulated expression of genes involved in peroxisomal lipid metabolism.

Conclusions

These results offer new insights into the impact of gut‐microbial metabolism of phenylalanine on host metabolism and atherosclerosis progression. Our findings suggest that clinical associations between phenylacetylglutamine and cardiovascular disease risk are unlikely to be driven by increased atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylacetatesAtherosclerosisGastrointestinal MicrobiomeLipid MetabolismAnimalsMaleFemaleDisease Models, AnimalHomeostasisPlaque, AtheroscleroticGlycineMiceMice, Knockout, ApoEGlutamineDiet, WesternMice, Inbred C57BL

Stichwörter der Autor:innen

atherosclerosiscardiovascular diseasegut microbesphenylacetic acidphenylacetylglutaminephenylacetylglycine

Substanzen

Phenylacetatesphenylacetic acidGlycinephenylacetylglutamineGlutaminephenylacetylglycine

Autor:innen und Institutionen

  • Department of Cardiovascular and Metabolic Sciences Cleveland Clinic Research Cleveland OH USA.
  • Center for Microbiome & Human Health Cleveland Clinic Cleveland OH USA.
  • Shared Laboratory Resources Cleveland Clinic Research, Cleveland Clinic Cleveland OH USA.
  • Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine Cleveland OH USA.

ORCID-Profile: Kelley M Carr, Jiyeon Kim, Junchul Shin, Kathryn A Bacik, Junyoung Hong, Christopher M Strauch, Naseer Sangwan, Olga A Cherepanova, Ina Nemet

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Carr, K. M., Kim, J., Shin, J., Bacik, K. A., Hong, J., Krukovets, I., Strauch, C. M., Sangwan, N., Cherepanova, O. A., & Nemet, I. (2026). Phenylacetic Acid, a Gut Microbially Produced Metabolite, Reduces Atherosclerosis Burden and Impacts Host Lipid Homeostasis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047044

Vancouver

Carr KM, Kim J, Shin J, Bacik KA, Hong J, Krukovets I, et al. Phenylacetic Acid, a Gut Microbially Produced Metabolite, Reduces Atherosclerosis Burden and Impacts Host Lipid Homeostasis. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.047044

BibTeX
@article{Carr2026,
  author = {Carr, Kelley M and Kim, Jiyeon and Shin, Junchul and Bacik, Kathryn A and Hong, Junyoung and Krukovets, Irene and Strauch, Christopher M and Sangwan, Naseer and Cherepanova, Olga A and Nemet, Ina},
  title = {Phenylacetic Acid, a Gut Microbially Produced Metabolite, Reduces Atherosclerosis Burden and Impacts Host Lipid Homeostasis},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.047044}
}
Kostenlos starten →